Nuveen Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-675,828
| Closed | -$26M | – | 3237 |
|
|
2023
Q2 | $26M | Sell |
675,828
-70,344
| -9% | -$2.7M | 0.01% | 907 |
|
|
2023
Q1 | $17.3M | Sell |
746,172
-170,593
| -19% | -$3.95M | 0.01% | 1139 |
|
|
2022
Q4 | $18.4M | Sell |
916,765
-44,493
| -5% | -$891K | 0.01% | 1101 |
|
|
2022
Q3 | $18.9M | Buy |
961,258
+336,054
| +54% | +$6.61M | 0.01% | 1049 |
|
|
2022
Q2 | $10.9M | Buy |
625,204
+410,711
| +191% | +$7.18M | ﹤0.01% | 1443 |
|
|
2022
Q1 | $3.51M | Buy |
214,493
+60,157
| +39% | +$984K | ﹤0.01% | 2249 |
|
|
2021
Q4 | $2.52M | Sell |
154,336
-23,819
| -13% | -$389K | ﹤0.01% | 2458 |
|
|
2021
Q3 | $2.27M | Sell |
178,155
-6,231
| -3% | -$79.5K | ﹤0.01% | 2613 |
|
|
2021
Q2 | $1.5M | Buy |
184,386
+111,751
| +154% | +$912K | ﹤0.01% | 2833 |
|
|
2021
Q1 | $1.03M | Sell |
72,635
-2,455
| -3% | -$34.7K | ﹤0.01% | 2875 |
|
|
2020
Q4 | $1.19M | Buy |
75,090
+5,281
| +8% | +$83.8K | ﹤0.01% | 2743 |
|
|
2020
Q3 | $848K | Sell |
69,809
-1,029
| -1% | -$12.5K | ﹤0.01% | 2752 |
|
|
2020
Q2 | $819K | Sell |
70,838
-13,355
| -16% | -$154K | ﹤0.01% | 2703 |
|
|
2020
Q1 | $1.15M | Buy |
+84,193
| New | +$1.15M | ﹤0.01% | 2452 |
|